|
JUPITER, Fla. -- BioQuest Technologies, Inc., a leading developer of innovative, environmentally safe antimicrobial products, announces it is educating athletic trainers from the NFL to high schools about the benefits of its new antimicrobial nanotechnology to aid athletic prevention and protection. As part of the company’s campaign to increase awareness and education about methicillin-resistant Staphylococcus aureus (MRSA) infections in athletics, it has partnered with CleenFreek SportsHygiene. CleenFreek presented BioQuest's patented microbiostatic antimicrobial nanotechnology utilized within the company's products and solutions to NFL athletic trainers looking for cutting -edge innovation to help reduce the spread of dangerous germs impacting athletes at alarming rates. Teams at all levels from professional to youth have started using CleenFreek's sport towels, yoga and exercise mats, and shower sandals that are designed to prevent the growth of bacteria, fungus, mold and mildew. CleenFreek's products are being used by a number of NFL teams including the New York Giants, St. Louis Rams, Tennessee Titans, Green Bay Packers, Denver Broncos, and Detroit Lions. Many colleges and universities are using CleenFreek as well, including major Division One schools such as the University of Georgia, University of Kansas, University of Illinois and many other colleges. One of the most pervasive problems in sports today is the spread of MRSA in team sports. CleenFreek's products are designed to prevent and kill bacteria (including MRSA), fungus, mold and mildew before they have a chance to migrate from player to player or surface to player. Junior Seau, 12-time NFL Pro-Bowl linebacker, knows about MRSA. "After contracting MRSA and being hospitalized, I learned first hand not to take my health for granted," said Seau. "As an 18-year veteran in the NFL, I want all athletes to get educated and protect their health from MRSA and staph, and that's why I use CleenFreek SportsHygiene. CleenFreek kills and prevents staph, MRSA, and germs. Listen, don't be complacent, take control, educate yourself, use CleenFreek in all athletic environments." Scott Seabaugh, president of CleenFreek, feels like the conference was a success. "We had a great response from professional football athletic trainers about the need for our SportsHygiene performance products and solutions that aid infectious disease prevention. BioQuest's patented technology represents a paradigm shift in antimicrobial thinking that will immediately impact our ability to aid athletic prevention and protection, while controlling germs. We're seeing among sports teams a shift in emphasis toward preventing the spread of infectious diseases, rather than treating the symptoms after the fact. Recent literature estimated the approximate amount to treat just one athlete contracted with MRSA will cost approximately $25,000. This figure includes hospitalization, but does not quantify team implications for having a key player miss games due to a MRSA outbreak. Based upon these statistics, it is easy to understand why prevention is very important." "Already this season, MRSA has had significant impact on sports programs across the country, leading to hospitalizations, canceled games, school closures, and death. This is tragic but we are committed to our leadership role in winning the war against staph, MRSA and germs," Seabaugh said. CleenFreek is a corporate partner and financial contributor to the MRSA Awareness Foundation, helping increase awareness and education of MRSA in sports and athletics. More information can be found at: www.mrsaawareness.com. Source: BioQuest Technologies, Inc.
|
